These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11563416)

  • 1. Evaluation of the acute and subchronic toxic effects in mice, rats, and monkeys of the genetically engineered and Escherichia coli cytosine deaminase gene-incorporated Salmonella strain, TAPET-CD, being developed as an antitumor agent.
    Lee KC; Zheng LM; Margitich D; Almassian B; King I
    Int J Toxicol; 2001; 20(4):207-17. PubMed ID: 11563416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.
    King I; Bermudes D; Lin S; Belcourt M; Pike J; Troy K; Le T; Ittensohn M; Mao J; Lang W; Runyan JD; Luo X; Li Z; Zheng LM
    Hum Gene Ther; 2002 Jul; 13(10):1225-33. PubMed ID: 12133275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.
    Nemunaitis J; Cunningham C; Senzer N; Kuhn J; Cramm J; Litz C; Cavagnolo R; Cahill A; Clairmont C; Sznol M
    Cancer Gene Ther; 2003 Oct; 10(10):737-44. PubMed ID: 14502226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours.
    Dresselaers T; Theys J; Nuyts S; Wouters B; de Bruijn E; Anné J; Lambin P; Van Hecke P; Landuyt W
    Br J Cancer; 2003 Nov; 89(9):1796-801. PubMed ID: 14583786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene.
    Gabel M; Kim JH; Kolozsvary A; Khil M; Freytag S
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):883-7. PubMed ID: 9652853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study.
    Kato H; Koshida K; Yokoyama K; Mizokami A; Namiki M
    Int J Urol; 2002 Oct; 9(10):567-76. PubMed ID: 12445236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor activity of the recombinant rClone30-CD/5-FC system].
    Lu Z; Zhang TY; Han MM; Bai FL; Wu W; Tian GY; Ren GP; Li DS
    Yao Xue Xue Bao; 2013 Feb; 48(2):261-8. PubMed ID: 23672024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver.
    Ohwada A; Hirschowitz EA; Crystal RG
    Hum Gene Ther; 1996 Aug; 7(13):1567-76. PubMed ID: 8864757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
    Consalvo M; Mullen CA; Modesti A; Musiani P; Allione A; Cavallo F; Giovarelli M; Forni G
    J Immunol; 1995 May; 154(10):5302-12. PubMed ID: 7730633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.